Dibenzazepine, a γ-Secretase Enzyme Inhibitor, Protects Against Doxorubicin-Induced Cardiotoxicity by Suppressing NF-κB, iNOS, and Hes1/Hey1 Expression

Linders, A.N., I.B. Dias, T.L. Fernández, C.G. Tocchetti, N. Bomer, and P. Van der Meer. 2024. A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging. NPJ Aging 10: 9. https://doi.org/10.1038/s41514-024-00135-7.

Article  PubMed  PubMed Central  Google Scholar 

Thorn, C.F., C. Oshiro, S. Marsh, T. Hernandez-Boussard, H. McLeod, T.E. Klein, and R.B. Altman. 2011. Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenetics and Genomics 21: 440–446. https://doi.org/10.1097/FPC.0b013e32833ffb56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jasim, S.T., H.M. Al-Kuraishy, and A.I. Al-Gareeb. 2019. Gingko Biloba protects cardiomyocytes against acute doxorubicin induced cardiotoxicity by suppressing oxidative stress. JPMA. The Journal of the Pakistan Medical Association 69 (3): S103–S107.

Google Scholar 

Ikeda, So., S. Matsushima, K. Okabe, M. Ikeda, A. Ishikita, T. Tadokoro, N. Enzan, et al. 2019. Blockade of L-type Ca2+ channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway. Scientific Reports 9: 9850. https://doi.org/10.1038/s41598-019-46367-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luu, A.Z., B. Chowdhury, M. Al-Omran, H. Teoh, D.A. Hess, and S. Verma. 2018. Role of endothelium in doxorubicin-induced cardiomyopathy. JACC. Basic to Translational Science 3: 861–870. https://doi.org/10.1016/j.jacbts.2018.06.005.

Article  PubMed  PubMed Central  Google Scholar 

Chen, R., M. Niu, H. Xin, and Y. He. 2023. Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity. Frontiers in Molecular Biosciences 10: 1241225. https://doi.org/10.3389/fmolb.2023.1241225.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Octavia, Y., C.G. Tocchetti, K.L. Gabrielson, S. Janssens, H.J. Crijns, and A.L. Moens. 2012. Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology 52: 1213–1225. https://doi.org/10.1016/j.yjmcc.2012.03.006.

Article  CAS  PubMed  Google Scholar 

Belger, C., C. Abrahams, A. Imamdin, and S. Lecour. 2024. Doxorubicin-induced cardiotoxicity and risk factors. International Journal of Cardiology Heart and Vasculature 50: 101332–101332.

Article  PubMed  Google Scholar 

Badr, A.M., and Y.F. Mahran. 2020. Notch pathway and its role in cardiovascular system: Review. Systematic Reviews in Pharmacy 11 (10): 342–349. https://doi.org/10.31838/srp.2020.10.56.

Perrimon, N., C. Pitsouli, and B.-Z. Shilo. 2012. Signaling mechanisms controlling cell fate and embryonic patterning. Cold Spring Harbor Perspectives in Biology 4: a005975. https://doi.org/10.1101/cshperspect.a005975.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun, J., M. Dong, X. Xiang, S. Zhang, and D. Wen. 2024. Notch signaling and targeted therapy in non-small cell lung cancer. Cancer Letters 216647. https://doi.org/10.1016/j.canlet.2024.216647.

Kopan, R. 2012. Notch signaling. Cold Spring Harbor Perspectives in Biology 4: a011213. https://doi.org/10.1101/cshperspect.a01121.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, Q., J. Li, J. Zheng, and A. Wei. 2019. The carcinogenic role of the notch signaling pathway in the development of hepatocellular carcinoma. Journal of Cancer 10: 1570–1579. https://doi.org/10.7150/jca.26847.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Golde, T.E., E.H. Koo, K.M. Felsenstein, B.A. Osborne, and L. Miele. 2013. γ-Secretase inhibitors and modulators. Biochimica Et Biophysica Acta 1828: 2898–2907. https://doi.org/10.1016/j.bbamem.2013.06.005.

Article  CAS  PubMed  Google Scholar 

Pandey, P., F. Khan, M. Choi, S.K. Singh, H.N. Kang, M.N. Park, S.-G. Ko, S.K. Sahu, R. Mazumder, and B. Kim. 2023. Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer. Biomedicine and Pharmacotherapy  Biomedecine and Pharmacotherapie 164: 114938. https://doi.org/10.1016/j.biopha.2023.114938.

Lawal B., A.T. Wu, C.H. Chen, T.A. George, and S.Y. Wu. 2023. Identification of INFG/STAT1/NOTCH3 as γ-Mangostin’s potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer. Biomedicine and Pharmacotherapy  Biomedecine and Pharmacotherapie 163: 114800. https://doi.org/10.1016/j.biopha.2023.114800.

Mei, H., Y. Ling, P. Ji, J. Yang, S. Fang, W. Guo, Y. Liu, and X. Chen. 2015. Doxorubicin activates the Notch signaling pathway in osteosarcoma. Oncology Letters 9: 2905–2909. https://doi.org/10.3892/ol.2015.3135.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian, T., F. Xiao, L. Jun, Z. Ruan, Y. Kejun Nan, Yao and Yujuan Yang. 2018. MicroRNA-760 Inhibits doxorubicin resistance in hepatocellular carcinoma through regulating Notch1/Hes1-PTEN/Akt signaling pathway. Journal of Biochemical and Molecular Toxicology 32: e22167. https://doi.org/10.1002/jbt.22167.

Article  CAS  PubMed  Google Scholar 

Vaish, V., J. Kim, and M. Shim. 2017. Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells. Oncotarget 8: 53262–53275. https://doi.org/10.18632/oncotarget.18391.

Article  PubMed  PubMed Central  Google Scholar 

BeLow, M., and C. Osipo. 2020. Notch signaling in breast cancer: A role in drug resistance. Cells 9: 2204. https://doi.org/10.3390/cells9102204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Venkatesh, V., R. Nataraj, G.S. Thangaraj, M. Karthikeyan, A. Gnanasekaran, S.B. Kaginelli, G. Kuppanna, C.G. Kallappa, and K.M. Basalingappa. 2018. Targeting Notch signalling pathway of cancer stem cells. Stem Cell Investigation 5. China: 5. https://doi.org/10.21037/sci.2018.02.02.

Øie, E., W.J. Sandberg, M.S. Ahmed, A. Yndestad, O.D. Lærum, H. Attramadal, P. Aukrust, and H.G. Eiken. 2010. Activation of Notch signaling in cardiomyocytes during post-infarction remodeling. Scandinavian Cardiovascular Journal: SCJ 44: 359–366. https://doi.org/10.3109/14017431.2010.511256.

Article  CAS  PubMed  Google Scholar 

Gude, N., and M. Sussman. 2012. Notch signaling and cardiac repair. Journal of Molecular and Cellular Cardiology 52: 1226–1232. https://doi.org/10.1016/j.yjmcc.2012.03.007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gude, N.A., G. Emmanuel, W. Weitao, C.T. Cottage, K. Fischer, P. Quijada, J.A. Muraski, et al. 2008. Activation of Notch-mediated protective signaling in the myocardium. Circulation Research 102: 1025–1035. https://doi.org/10.1161/CIRCRESAHA.107.164749.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kratsios, P., C. Catela, E. Salimova, M. Huth, V. Berno, N. Rosenthal, and F. Mourkioti. 2010. Distinct roles for cell-autonomous Notch signaling in cardiomyocytes of the embryonic and adult heart. Circulation Research 106: 559–572. https://doi.org/10.1161/CIRCRESAHA.109.203034.

Article  CAS  PubMed  Google Scholar 

Rizzo, P., D. Mele, C. Caliceti, M. Pannella, C. Fortini, A.G. Clementz, M.B. Morelli, G. Aquila, P. Ameri, and R. Ferrari. 2014. The role of notch in the cardiovascular system: Potential adverse effects of investigational notch inhibitors. Frontiers in Oncology 4: 384. https://doi.org/10.3389/fonc.2014.00384.

Article  PubMed  Google Scholar 

Campa, V.M., R. Gutiérrez-Lanza, F. Cerignoli, R. Díaz-Trelles, B. Nelson, T. Tsuji, M. Barcova, W. Jiang, and M. Mercola. 2008. Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. The Journal of Cell Biology 183: 129–141. https://doi.org/10.1083/jcb.200806104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng, J., S. Zhang, and T. Wang. 2019. Expression of Notch-1 and nuclear factor-κB signal pathway in myocardial cells of coronary heart disease rats. Experimental and Therapeutic Medicine 17: 1587–1592. https://doi.org/10.3892/etm.2018.7123.

Article  CAS  PubMed  Google Scholar 

Milano, J., J. McKay, C. Dagenais, L. Foster-Brown, F. Pognan, R. Gadient, R.T. Jacobs, A. Zacco, B. Greenberg, and P.J. Ciaccio. 2004. Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicological Sciences: An Official Journal of the Society of Toxicology 82: 341–358. https://doi.org/10.1093/toxsci/kfh254.

Article  CAS  PubMed  Google Scholar 

Mantawy, E.M., W.M. El-Bakly, A. Esmat, A.M. Badr, and E. El-Demerdash. 2014. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. European Journal of Pharmacology 728. https://doi.org/10.1016/j.ejphar.2014.01.065.

Mathias, L.M., B. Simões, P.H.C. Alegre, I. de Oliveira, F. Dos Santos, T. Bachiega, A.M. Figueiredo, F. Chiuso-Minicucci, A.A. Fernandes, et al. 2019. Euterpe oleracea mart. (Açai) supplementation attenuates acute

Comments (0)

No login
gif